A district court judge granted summary judgment of non-infringement to ICU Medical Inc. on Friday, finding that the company’s needle-free intravenous connector does not infringe rival Medegen MMS Inc.’s patent.
A federal judge has dismissed a proposed class action lawsuit that accused Encysive Pharmaceuticals Inc. of misleading investors about the prospects for its pulmonary arterial hypertension treatment Thelin.
Johnson & Johnson subsidiary Conor Medsystems has reached a settlement with Angiotech Pharmaceuticals Inc. to resolve litigation regarding drug-eluting stents used in cancer chemotherapy.
A state court has thwarted a Kansas ban that would have prohibited most physicians from carrying out a procedure that shrinks down patients’ body fat.
A judge in the average wholesale price multidistrict litigation has agreed to move suits brought by the states of Nevada and Montana back to the states' federal courts.
Altana Pharma AG has lost another bulwark against competition for its hit ulcer and heartburn drug Protonix, now that the stays that went into effect in 2005 have expired and a judge has declined to block Sun Pharmaceuticals Industries Ltd. and Teva Pharmaceutical Industries Ltd. from marketing generics.
A federal court in Canada has ruled that Pfizer Inc.’s patent covering the key ingredient in Lipitor would be infringed by Ranbaxy Laboratories Ltd.’s method for developing a generic copy of the cholesterol-lowering drug.
Bank of America NA has been handed a victory in a long-running lawsuit, with a district court judge declining to toss a jury verdict declaring TradeCard Inc.'s patent for a purchase order processing system invalid.
Israeli drug company Teva Pharmaceutical Industries Ltd. has reached an agreement with Dr. Reddy’s Laboratories Inc. and agreed to drop a patent infringement suit filed against the Indian drug maker over its generic version of the antidepressant Zoloft.
In a major setback for Apotex Inc., a federal judge has found that the Canadian drug maker’s application for a generic version of anti-inflammatory eye treatment Acular infringed a patent held by Roche Palo Alto LLC and licensed to Allergan LLC.
Canadian drug maker Biovail Inc. has reached a settlement with Banc of America Securities LLC and one of the bank's former traders, agreeing to drop claims against them from a lawsuit accusing several hedge funds and brokers of conspiring to drive down its stock price.
French drug giant Sanofi-Aventis will hand over more than $190 million to settle claims by the U.S. Department of Justice and various states that its predecessor defrauded Medicare by inflating the reported average wholesale price of a cancer drug.
A judge has given his final approval to a $52.5 million settlement agreement in two related securities cases filed against pharmaceutical company Sepracor Inc. over the company's alleged concealment of safety concerns about its antihistamine drug, Soltara.
ImClone Systems Inc. will shell out $65 million as part of a settlement with Repligen Corp. and the Massachusetts Institute of Technology to resolve Repligen and MIT's 2004 patent suit against Imclone over its cancer treatment Erbitux.
Drug maker Eli Lilly & Co. has reached a settlement with a doctor who breached a protective order after handing over confidential documents to a plaintiffs' lawyer in the Zyprexa product liability litigation.
Enzo Biochem Inc. has appealed a court’s decision to grant Applera Corp.’s summary judgment motion of invalidity in a patent infringement suit over DNA detection technology.
The wife of the former CEO of Cubist Pharmaceuticals, her brother and his neighbor have settled insider trading allegations brought by the U.S. Securities and Exchange Commission regarding the company's common stock.
Handing Merck & Co. a victory, the New Jersey Supreme Court on Thursday reversed a lower court ruling that certified a nationwide class of Vioxx consumers attempting to get back the money they spent on the drug.
Drug-maker Ortho-McNeil Inc. has been fighting with generic makers Barr Laboratories Inc. and Caraco Pharmaceutical Laboratories Ltd. over its request to vacate a summary judgment ruling in the dispute over its patent for the painkiller Ultracet.
A federal appeals court panel has upheld both the validity of Forest Laboratories Inc.’s patent on the blockbuster antidepressant drug Lexapro and an injunction thwarting Ivax Pharmaceuticals Corp.’s plans to market a generic.